Genmab — December 2017

[E_L]

where PR mentioned how those trials had waiting lists for 1 year, and patients where carefully selected and vetted

[Bulder]

It's been posted 3 times already

[E_L]

this offcourse to get best results in such a small study

[E_L]

and i still couldnt find it back. forget it lol

[Graneman]

Juno er nu nede med 25% siden mandag. 7% bare i dag.
Just sayin'.

[Helge_LarsenPI-redaktør]

Very young patients in the study.

[Bulder]

but here it is https://www.youtube.com/watch?v=oqA2H5Q-YmQ&t=24s

[E_L]

yeah, ok, i would have still prefered to have had Juno this year mate...still more then doubled...

[E_L]

thanks

[E_L]

must watch for everyone

[JKY_VH]

Tak Graneman. Det tager jeg som et tegn på, at fornuften er på vej tilbage.

[E_L]

Genmab mention, even though at some point they mix up € and DKK http://mondaymorning.com/2017/12/14/from-across-the-pond-2017s-brightest-european-biotech-stars-perhaps-under-uss-radar-but-still-ready-to-soar/

[Graneman]

Sandt nok, E L, men perspektivet til den påståede stormende succes for CAR-T på ASH skal altså lige ses i lyset af faldet på de 25% på bare fire dage. Det lugter ikke ligefrem af en Darzalex-killer.

[Bulder]

Nu er det også Bluebirds bb2121, der har været i focus. BB steg 20% i mandags, men er siden faldet 3 dage i træk.

[E_L]

true. lets hope realism and nuance is kicking in...

[JørgenVarnæs]

NBI er nede med 1,5% - så skal vi vel op med 6-7% i morgen

[Bulder]

Pengene fra Juno og BB skal vel tilbage til genmab?

[JKY_VH]

præcis Bulder

[bibob]

De finder vel snart ud af at der er kun een KING

[JørgenVarnæs]

JJ?